Clinical pathway

HMP's Journal of Clinical Pathways and Association of Community Cancer Centers Announce Collaboration

Retrieved on: 
Tuesday, October 22, 2019

MALVERN, Pa., Oct. 22, 2019 /PRNewswire-PRWeb/ --HMP, a leader in health care events and education, today announced that its peer-reviewed publication, Journal of Clinical Pathways, has formed a strategic partnership with the Association of Community Cancer Centers (ACCC), a leading education and advocacy organization for the cancer care community.

Key Points: 
  • MALVERN, Pa., Oct. 22, 2019 /PRNewswire-PRWeb/ --HMP, a leader in health care events and education, today announced that its peer-reviewed publication, Journal of Clinical Pathways, has formed a strategic partnership with the Association of Community Cancer Centers (ACCC), a leading education and advocacy organization for the cancer care community.
  • Dr. Frisk will provide the journal with expert guidance on the changing landscape of value-based cancer care and reimbursement models.
  • Journal of Clinical Pathways addresses the potential of clinical pathways to address rising health care costs, mitigate patient risk, reduce variability, and achieve better, more predictable clinical outcomes.
  • The Association of Community Cancer Centers (ACCC) is the leading education and advocacy organization for the cancer care community.

National Osteoporosis Foundation Supports New Evidence-Based Care Pathway Designed to Optimize Care for Vertebral Compression Fractures (VCF)

Retrieved on: 
Monday, September 16, 2019

NOF has recently recorded and featured a discussion of the VCF Care Pathway on the NOF Bone Talk podcast.

Key Points: 
  • NOF has recently recorded and featured a discussion of the VCF Care Pathway on the NOF Bone Talk podcast.
  • Our goal in working to integrate the VCF Care Pathway algorithm into commercially-available electronic medical records is to standardize and optimize care for VCF patients regardless of where in the care continuum they present.
  • The NOF supports the development and implementation of the VCF Care Pathway, saidElizabeth Thompson, CEO of the National Osteoporosis Foundation.
  • Management of vertebral fragility fractures: a clinical care pathway developed by a multispecialty panel using the RAND/UCLA Appropriateness Method.

Itamar Medical to Present at the Ladenburg Thalmann 2019 Healthcare Conference on September 24, 2019

Retrieved on: 
Tuesday, September 10, 2019

A live and archived webcast of the presentation will be available on the investor section of the Companys website at: www.itamar-medical.com .

Key Points: 
  • A live and archived webcast of the presentation will be available on the investor section of the Companys website at: www.itamar-medical.com .
  • For more information about the conference, or to schedule a one-on-one meeting with Itamar Medicals management, please contact your Ladenburg Thalmann representative.
  • The Company offers a Total Sleep Solution to help physicians provide comprehensive sleep apnea management in a variety of clinical environments to optimize patient care and reduce healthcare costs.
  • Its digital health platform, including CloudPAT and SleePATh, facilitates seamless and complete care pathway management in a complex environment.

HMP's Oncology Clinical Pathways Congress Partners with the Community Oncology Alliance

Retrieved on: 
Wednesday, July 10, 2019

MALVERN, Pa., July 10, 2019 /PRNewswire-PRWeb/ --HMP, a leader in healthcare events and education, today announced the Community Oncology Alliance (COA) as an official partner of the Oncology Clinical Pathways Congress, taking place October 11-13, 2019 in Boston.

Key Points: 
  • MALVERN, Pa., July 10, 2019 /PRNewswire-PRWeb/ --HMP, a leader in healthcare events and education, today announced the Community Oncology Alliance (COA) as an official partner of the Oncology Clinical Pathways Congress, taking place October 11-13, 2019 in Boston.
  • Launched in 2016, the Congress is the official meeting of the Journal of Clinical Pathways and focuses on the expansion of clinical pathways as a decision support tool and their increasing influence on patient care.
  • The 2019 Congress will delve into three key topic areas:
    Implementation: Develop a successful, evidence-based pathways program that delivers optimal patient care.
  • "We are honored to partner with the Community Oncology Alliance," said Randy Robbin, president, NACCME, the medical education subsidiary of HMP.

Global Splenomegaly Therapeutics Market 2019-2023 - Rising Awareness of Splenomegaly & Challenges Associated with Diagnosis

Retrieved on: 
Tuesday, April 16, 2019

DUBLIN, April 16, 2019 /PRNewswire/ -- The "Global Splenomegaly Therapeutics Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, April 16, 2019 /PRNewswire/ -- The "Global Splenomegaly Therapeutics Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.
  • The splenomegaly therapeutics market will register a CAGR of almost 3% by 2023.
  • The availability of clinical practice guidelines improves the quality of life of patients, as well as the consistency of care.
  • There are several guidelines and care pathways for the management of splenomegaly, which have been developed by hospitals and professional societies.

Global Splenomegaly Therapeutics Market (2019-2023) to Exhibit a CAGR of Approx 3% - Analysis by Product, Type and Geography - ResearchAndMarkets.com

Retrieved on: 
Monday, April 8, 2019

The splenomegaly therapeutics market will register a CAGR of almost 3% by 2023.

Key Points: 
  • The splenomegaly therapeutics market will register a CAGR of almost 3% by 2023.
  • The availability of clinical practice guidelines improves the quality of life of patients, as well as the consistency of care.
  • There are several guidelines and care pathways for the management of splenomegaly, which have been developed by hospitals and professional societies.
  • These are published and practiced with the aim of standardizing disease management in patients with splenomegaly.

Great Ormond Street Hospital and Elsevier see Success With Arezzo

Retrieved on: 
Tuesday, August 28, 2018

The implementation of Arezzo at GOSH is helping doctors and nurses make smarter care decisions.

Key Points: 
  • The implementation of Arezzo at GOSH is helping doctors and nurses make smarter care decisions.
  • Arezzo takes medical guidelines, protocols, and order sets, combines them with relevant patient information and presents personalized patient pathways and testing advice to clinicians.
  • The result is an efficient process from the decision-to-admit, to the decision-to-treat based on the results of the investigations performed.
  • "Arezzo is helping the medical staff analyze the situation and deliver care pathway suggestions based on each patient's personal needs.

Machine Learning, Care Transitions, and Clinical Pathways Reduce CHF Readmissions by 46%

Retrieved on: 
Monday, May 21, 2018

This achievement stems from the marriage of a dynamic patient management solution driving care transitions and the clinical pathway protocols at HRS Home Health.

Key Points: 
  • This achievement stems from the marriage of a dynamic patient management solution driving care transitions and the clinical pathway protocols at HRS Home Health.
  • The CHF patient population, notably one of the most highly readmitted diagnostic groups nationwide, has been engaged in this approach during the last six months.
  • The CHF program utilizes the dynamic patient management system, provided by Wanda, Inc., which is embedded with machine learning to power the clinical decision process.
  • "As providers, we are imbuing clinical processes with modern technology, which empowers our clinical teams with real-time actionable information to improve patient care.